Stock Watch: Can Acadia’s Rett Syndrome Drug Succeed?
Might Trofinetide’s Clinical Efficacy Be Eclipsed By Safety Profile?
Executive Summary
In a rare disease indication, clinical trial efficacy in Phase III should be the ticket to successful sales. But safety issues warrant careful consideration.